Post

New research · Rheumatology
Annals of the rheumatic diseases · 2d
Cohort studyAnnals of the rheumatic diseases · 2026

Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal insights from the Karolinska Risk-RA cohort.

Yogan Kisten, Alexandra Cîrciumaru, Marina Dehara … Lars Klareskog
Read paper
RheumatologyCohort study

Any ultrasound finding at baseline is associated with a higher risk of clinical arthritis.

Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal insights from the Karolinska Risk-RA cohort.

Yogan Kisten et al. · Annals of the rheumatic diseases · 2026
Purpose

This study aimed to investigate whether ultrasound (US)-detected features preceding Doppler-active synovitis are associated with progression to clinical arthritis in anticitrullinated protein antibody (ACPA)-positive individuals with musculoskeletal (MSK) symptoms.

Methods

In this prospective cohort study, 309 ACPA-positive individuals with MSK symptoms but without clinical arthritis and Doppler-active synovitis were included.

n = 309 participants
Results

any ultrasound finding at baseline means a 3-fold higher chance of developing arthritis

HR 3.30 (95% CI 2.30 to 4.80)
null 1
2.30
4.80
CI excludes the null - significant
More results

Among these, tendon sheath involvement showed the strongest association (HR 3.6, 95% CI 2.4-5.4), especially in combination with IgM RF positivity (HR 4.2, 95% CI 2.7-6.4).

Tendon involvement frequently preceded synovial changes.

“
Conclusion

Minimal US findings preceding Doppler-active synovitis, particularly tendon involvement, were strongly associated with progression to clinical arthritis in ACPA-positive individuals and support an US-identified 'presynovitis' phase of rheumatoid arthritis development and early risk stratification.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Review
34.6%
Complete renal remission was achieved in 34.6% of patients receiving high-dose glucocorticoids.
Cohort Study
AUC of 0.804
how well the three-gene model identifies Dampness ZHENG
Cohort Study
OR = 0.220
belimumab was linked to a lower chance of lupus kidney disease symptoms returning